Ketamine Infusion Therapy Cost in Miami, FL
Ketamine Infusion Therapy in Miami typically costs $413 to $1,003, with a median price of $620. That places Miami 18% above the national average for this procedure in 2026.
Get matched with Ketamine Infusion Therapy clinics in Miami, FL
Free, no obligation. We send your request to 2-4 verified clinics for quotes and financing options.
How much does ketamine infusion therapy cost in Miami, FL in 2026? Ketamine Infusion Therapy in Miami, FL costs between $413 and $1,003 in 2026, with most patients paying around $620 (per infusion (induction series typically 6 infusions)). This is 18% above the national average (national median: $525). Pricing varies based on induction series (6 infusions), maintenance infusions, ketamine-assisted psychotherapy (kap) integration, plus provider experience and facility type.
Evidence: IV ketamine has substantial published evidence for rapid antidepressant effects in treatment-resistant depression, including multiple RCTs showing 60-70% response rates and 30-40% remission rates after a single infusion. Effects typically last 1-2 weeks per infusion. Spravato (esketamine nasal spray, FDA-approved 2019) is the FDA-approved version for treatment-resistant depression and major depression with acute suicidal ideation. IV ketamine is used off-label but has more years of clinical evidence than Spravato.
Regulatory status: Ketamine is a Schedule III controlled substance, FDA-approved as an anesthetic. Use for depression is off-label. Administered by physicians (anesthesiologists, psychiatrists, pain specialists, emergency physicians) or under direct physician supervision. The DEA has expressed concern about telehealth at-home ketamine prescribing models and tightened oversight in 2023-2024.
What Ketamine Infusion Therapy Is
IV infusion of ketamine at sub-anesthetic dose (typically 0.5 mg/kg over 40 minutes) administered in a clinical setting with monitoring. Patient remains conscious but experiences dissociative effects during the infusion. Most clinical protocols include 6 induction infusions over 2-3 weeks.
Who It Is For
Adults with treatment-resistant depression (failed at least 2 adequate antidepressant trials), severe major depression with suicidal ideation, PTSD, treatment-resistant bipolar depression (in conjunction with mood stabilizers), or certain chronic pain conditions including complex regional pain syndrome. Less appropriate for: mild depression (first-line treatments preferred), active psychosis or schizophrenia, uncontrolled hypertension, history of severe substance abuse (ketamine has abuse potential).
What Is Typically Included in Miami Pricing
Most Miami-area quotes for Ketamine Infusion Therapy include the items below. Always request a written inclusion list before booking.
- Pre-treatment psychiatric screening and medical clearance
- Single infusion session (40-60 minutes)
- Vital sign monitoring before, during, and after
- Discharge after sufficient recovery (typically 30-60 minutes post-infusion)
- Outcome assessment (PHQ-9, GAD-7, or similar standardized measures)
Often Not Included (Verify Before Booking)
- Initial psychiatric evaluation if not already established (typically $300-$600 additional)
- Integration therapy (often offered as add-on at $150-$300/session)
- Maintenance infusions beyond induction protocol
- Transportation home after infusion (patients should not drive for 12-24 hours)
- Underlying psychiatric medication management (typically separate)
Procedure Snapshot
- Category
- Mental Health
- Total timeline
- 1 day
- Typical recovery
- 0 days
- National range
- $350 - $850
- Miami range
- $413 - $1,003
- Cost unit
- per infusion (induction series typically 6 infusions)
- Financing common
- Yes
- Evidence level
- FDA-Approved (Off-Label Use)
What Drives Ketamine Infusion Therapy Cost in Miami
These factors most commonly move Ketamine Infusion Therapy pricing up or down in the Miami market. Ask Miami clinics about each item when comparing quotes.
Induction series (6 infusions)
Standard 6-infusion induction over 2-3 weeks. Some clinics offer package pricing 5-15% below per-session rate.
Maintenance infusions
Ongoing infusions every 2-8 weeks (highly variable by patient response).
Ketamine-assisted psychotherapy (KAP) integration
Therapy session added before or after infusion to maximize therapeutic integration. Adds $150-$350 per session.
Geographic location
NYC, SF, LA premium clinics charge 30-50% above mid-tier markets.
Provider type
Psychiatrist-led clinics typically charge more than anesthesiologist-led clinics. Outcomes are comparable when protocols are appropriate.
Spravato (FDA-approved alternative)
Spravato (esketamine) has insurance coverage pathways that can substantially reduce out-of-pocket cost vs cash IV ketamine.
Insurance and Coverage for Ketamine Infusion Therapy in Miami
IV ketamine is rarely covered by US insurance because it is used off-label. Spravato (FDA-approved esketamine) has insurance coverage pathways with prior authorization. For patients seeking insurance-covered ketamine treatment, Spravato is typically the financial path.
Typical coverage: IV ketamine 0% typical; Spravato 80-100% after deductible with prior authorization
Prior authorization typically required.
State-specific notes
International Cost Comparison
How Ketamine Infusion Therapy pricing in Miami compares to major international medical tourism destinations. Quality, credentialing, and follow-up logistics vary substantially - verification is critical before traveling for care.
| Country / City | Typical Cost | Notes | Pros / Cons |
|---|---|---|---|
| Mexico (Tijuana / Cancun / Mexico City) | $200-$400 per infusion | Limited US patient flow; less established medical tourism for ketamine specifically. Most Mexico ketamine is for anesthetic use rather than psychiatric. | + 40-60% below US pricing - Less established protocols for psychiatric ketamine; verify clinic credentials carefully |
| Canada (Toronto / Vancouver) | $350-$600 USD per infusion | Similar protocols to US. Insurance coverage variable. | + Comparable quality to US; English-speaking - Travel cost; similar pricing to mid-tier US clinics |
| UK (London) | $500-$900 USD per infusion | Private clinics operate similar to US; NHS provides Spravato in specialized centers. | + Quality clinical infrastructure - Higher cost than US in many cases; significant travel from US |
Pre-Procedure Checklist
Steps to complete before your scheduled ketamine infusion therapy to maximize outcomes and minimize complications.
- Complete pre-treatment psychiatric evaluation and confirm treatment-resistant depression diagnosis
- Document at least 2 adequate antidepressant trials at appropriate doses for adequate duration
- Medical clearance: BP controlled, no contraindications identified
- Coordinate with outside psychiatrist on continuation of current medications
- Avoid alcohol and recreational drugs for 24-48 hours before infusion
- Take any required pre-medication (anti-emetic if prescribed)
- Arrange transportation home (no driving for 12-24 hours)
- Plan quiet evening with minimal social or stimulating activities
- Light meal 2-3 hours before; avoid heavy meals 1 hour before
- Wear comfortable clothing
How the Procedure Works
Step-by-step overview of Ketamine Infusion Therapy.
- 1
Pre-treatment evaluation
60-90 minutesComprehensive psychiatric evaluation: diagnosis confirmation, treatment history (must document adequate trials of 2+ standard antidepressants for TRD), medical clearance for cardiovascular and psychiatric contraindications, baseline PHQ-9 and GAD-7 scoring.
- 2
Informed consent and education
30 minutes (often part of evaluation)Detailed discussion of expected experience (dissociative effects), realistic outcome probabilities (60-70% response rate, 30-40% remission), risks, and what to expect during and after infusion.
- 3
Infusion preparation
15-20 minutesIV catheter placement, vital sign baseline (BP, heart rate, oxygen saturation). Patient settles into a recliner or treatment chair. Calming environment with low lighting and option for music or eye mask.
- 4
Infusion administration
40 minutesKetamine 0.5 mg/kg infused over 40 minutes. Patient experiences dissociative effects starting at 5-10 minutes - feeling disconnected from body, altered time perception, sometimes visual phenomena. Patient remains conscious and can communicate but typically does not want to.
- 5
Post-infusion monitoring
30-60 minutesVital signs monitored for 30-60 minutes after infusion ends. Dissociative effects subside. Some patients experience emotional release, insight, or temporary anxiety. Trained staff support as needed.
- 6
Discharge with support
15 minutesPatient discharged with a responsible adult (no driving for 12-24 hours). Recommended quiet evening with minimal stimulation. Some clinics include same-day check-in via app or phone.
- 7
Repeat for full induction series
2-3 weeks totalSteps 3-6 repeat for total of 6 infusions over 2-3 weeks. Most patients receive 2-3 infusions per week.
- 8
Outcome assessment and maintenance planning
60 minutesAfter completion of induction series, response is assessed via PHQ-9 and clinical interview. Responders move to maintenance protocol (typically every 2-8 weeks based on individual durability). Non-responders may discontinue or trial alternative protocols.
Recovery Timeline
What to expect day by day and month by month after Ketamine Infusion Therapy.
Aftercare and Long-Term Maintenance
Recommended care after ketamine infusion therapy to maintain results and prevent complications.
Patient Experience: What to Expect
Composite patient experiences across stages of the ketamine infusion therapy journey, drawn from aggregated reported experiences and clinical observation.
Most patients arrive at ketamine consideration after multiple failed antidepressant trials. The evaluation is a meaningful clinical interaction - thorough psychiatric history, validation of treatment-resistant status, and education about realistic expectations. Quality clinics spend 60-90 minutes on this evaluation.
Most patients describe pre-infusion anxiety about the dissociative experience. Quality clinics provide eye masks, music, and supportive staff. The infusion itself feels much less dramatic than the anxiety predicted - patients describe time passing oddly but the experience being more interesting than frightening for most.
Dissociation peaks at minute 20-30 of the 40-minute infusion. Patients describe time distortion, feeling detached from the body, sometimes visual phenomena (especially with eyes closed), and occasionally profound emotional experiences. Most patients have minimal interest in talking or moving during the peak.
Dissociation subsides over 30 minutes after infusion ends. Patients are groggy but conscious. Some experience immediate emotional release (crying, laughter, insight). Most prefer quiet rest after returning home. No driving allowed for 12-24 hours.
Many patients describe an "antidepressant lift" within 24-48 hours - feeling clearer, more hopeful, more energetic. For some this is the first relief from depression in years. For 30-40% of patients, the lift is modest or absent. This early signal predicts but does not determine series response.
Most responders see progressive improvement across infusions 2-6. Sleep often improves, appetite returns, anhedonia (inability to feel pleasure) lifts. Some patients describe a "window of clarity" they have not experienced in years.
Responders enter what many describe as the most stable period of mental health they have experienced. Maintenance infusions begin. Most patients use this window for behavioral change, therapy, lifestyle work, and rebuilding routines that depression had eroded.
Many patients maintain on periodic infusions every 2-8 weeks. Some achieve sustained remission and taper to less frequent infusions or discontinue. The treatment is widely described as life-changing by responders. Non-responders move to alternative treatments (Spravato, TMS, ECT).
Risks and Complications
Documented risks and their typical frequency in published clinical data.
Dissociation during infusion
common (expected effect)100% of patients experience some level of dissociation during the infusion. For most this is acceptable or pleasant. Approximately 5-10% find it distressing enough to discontinue treatment after 1-2 sessions.
Nausea and vomiting
uncommon10-15% of patients experience nausea during or after infusion. Anti-emetics (ondansetron) before infusion substantially reduces this.
Blood pressure elevation
common (transient)Ketamine increases blood pressure 15-25 mmHg during infusion. Returns to baseline within 30 minutes. Patients with uncontrolled hypertension should not receive infusion until BP controlled.
Anxiety or panic during infusion
uncommon5-10% of patients experience anxiety or panic during dissociative effects. Mitigated by experienced staff, comfortable environment, and pre-treatment education. Pre-medication with low-dose benzodiazepine helpful for anxious patients.
Bladder dysfunction (cystitis)
rare in therapeutic useChronic high-dose ketamine abuse causes ulcerative cystitis. Therapeutic dosing for depression does not appear to carry this risk at recommended intervals. Patients on high-frequency long-term maintenance should be monitored.
Liver function changes
rareOccasional liver enzyme elevations in long-term frequent maintenance. Baseline and periodic liver function tests appropriate for patients on extended treatment.
Substance abuse potential
rare in controlled settingKetamine has abuse potential. Clinical IV ketamine in controlled settings has minimal abuse risk. At-home prescription protocols (where ketamine is taken outside clinical observation) have substantially higher abuse risk and DEA scrutiny.
Inadequate response or non-response
common30-40% of treatment-resistant depression patients do not achieve meaningful response to ketamine. Some respond initially then lose effect. Alternative treatments (Spravato, TMS, ECT) may be appropriate next steps.
Financing Ketamine Infusion Therapy in Miami
Most Miami-area clinics offering Ketamine Infusion Therapy accept patient financing through CareCredit, Alphaeon Credit, or Proceed Finance. Below are estimated monthly payments for the Miami median cost of $620. Actual rates depend on credit profile and approval.
Financing Options at $620
Estimated monthly payments for the median cost. Actual rates depend on credit and provider.
| Provider | Term | Est. APR | Est. Monthly | Apply |
|---|---|---|---|---|
| CareCredit | 24 months | 17.9% | $30.92/mo | Check rate → |
| Alphaeon Credit | 36 months | 14.9% | $21.46/mo | Check rate → |
| Proceed Finance | 60 months | 12.9% | $14.08/mo | Check rate → |
ProcedureFinder may earn a commission from financing applications. Full disclosures.
Alternatives to Ketamine Infusion Therapy
Other approaches to the same condition or goal, with cost and tradeoff comparisons.
Spravato (esketamine nasal spray)
FDA-approved esketamine for treatment-resistant depression and major depression with acute suicidality. Same mechanism as IV ketamine. Insurance-coverable with prior authorization. Administered in clinic for 2-hour monitored sessions.
TMS (Transcranial Magnetic Stimulation)
Non-invasive brain stimulation, no medication. FDA-approved for treatment-resistant depression. 30-40 sessions over 6-8 weeks. Comparable response rates to ketamine for depression but different mechanism and slower onset.
ECT (Electroconvulsive Therapy)
Most effective treatment for severe depression with 70-80% response rates. Requires anesthesia, has cognitive side effects (typically transient), highest tier of treatment-resistant care. Insurance-covered.
At-home ketamine telehealth (oral or sublingual)
Oral or sublingual ketamine prescribed via telehealth (Mindbloom, Joyous, Better U, others). Less monitoring, less consistent dosing absorption, lower cost. DEA scrutiny in 2023-2026 has tightened legal availability. Effectiveness vs IV is debated; IV is the more-established and better-studied route.
Traditional antidepressants (third-line trial)
After 2 failed antidepressant trials, additional antidepressant trials (different class, augmentation with lithium or atypical antipsychotic) remain reasonable next steps before or in parallel with ketamine.
Ketamine Infusion Therapy Cost Comparison Across Metros
See how Ketamine Infusion Therapy pricing in Miami compares to nearby and major US markets.
Provider Credentials Guide for Ketamine Infusion Therapy
Which credentials matter most when selecting a Miami provider for ketamine infusion therapy, and how to verify them.
Board certification in Psychiatry, Anesthesiology, or Emergency Medicine
criticalHow to verify: Verify via ABPN.com (psychiatry), ABA.org (anesthesiology), or ABEM.org (emergency medicine). Most quality ketamine clinics are led by board-certified physicians in one of these specialties.
ASKP3 membership (American Society of Ketamine Physicians, Psychotherapists, and Practitioners)
importantHow to verify: Search askp.org. Indicates engagement with the specialty's evolving best practices and standards.
Outcome tracking and willingness to share data
criticalHow to verify: Ask: "What are your response and remission rates for treatment-resistant depression?" Quality clinics track PHQ-9 and GAD-7 across patients and can quote outcomes.
Coordination with outside psychiatrist
importantHow to verify: Quality clinics coordinate care rather than operate as standalone interventions. Ask about their communication practices with primary psychiatry.
Integration therapy availability
helpfulHow to verify: Ketamine-assisted psychotherapy (KAP) integration enhances long-term durability. Quality clinics either offer this in-house or refer to specialized therapists.
On-site emergency capability
criticalHow to verify: Adverse events are rare but require capable response. Confirm the clinic has emergency medications (anti-emetics, anti-hypertensives, benzodiazepines for severe dissociation) and trained staff present during all infusions.
Red Flags When Choosing a Miami Clinic
Patterns to watch for when comparing Ketamine Infusion Therapy providers.
- No psychiatric evaluation required before infusion (only "medical clearance")
- No prior antidepressant trial requirement (treating all patients with ketamine first-line)
- Marketing as "miracle cure" or for indications without evidence (anxiety alone, addiction, weight loss)
- Treatment recommended for patients with active psychosis or schizophrenia
- No outcome tracking (PHQ-9, GAD-7) or willingness to discuss response rates
- No integration therapy offered or recommended
- Pricing significantly below market (under $300/infusion in the US is concerning)
- No monitoring during infusion or inexperienced staff
- No protocol for managing anxiety/panic during infusion
- Unwillingness to coordinate with the patient's outside psychiatrist
Questions to Ask Any Miami Provider
Use this list during consultations. Reputable providers will answer all of them clearly and in writing.
- What is your response rate and remission rate for patients with treatment-resistant depression?
- Will I be monitored continuously during the infusion, and by whom?
- What is your protocol for managing anxiety or distress during infusion?
- Do you offer integration therapy, and is it included or separate?
- How do you coordinate care with my outside psychiatrist and primary care?
- What is your protocol if I do not respond to the induction series?
- Are you a board-certified physician, and what specialty (psychiatry, anesthesiology, etc.)?
- What outcome measures do you use to track my response (PHQ-9, GAD-7)?
- What is your approach to maintenance protocol after induction?
- Are infusions performed in a comfortable private setting, or in a shared space?
Frequently Asked Questions
Answers to the most-searched questions about Ketamine Infusion Therapy cost and treatment.
How much does a ketamine treatment series cost? +
The standard 6-infusion induction protocol typically runs $2,400 to $5,100 total in the US, with a median around $3,000. Per-infusion cost is $350-$850 depending on location and provider. Maintenance infusions afterward run $350-$850 each at variable frequency (every 2-8 weeks typical).
Is ketamine therapy covered by insurance? +
Most US insurance does not cover off-label IV ketamine. Spravato (the FDA-approved esketamine nasal spray) is more frequently covered with prior authorization. For patients with treatment-resistant depression seeking insurance-covered options, Spravato is typically the better financial path. Some HSA/FSA funds can be used for IV ketamine as qualified medical expense when prescribed for a documented diagnosis.
How often do I need ketamine infusions? +
Standard induction is 6 infusions over 2-3 weeks (typically 2-3 per week). Maintenance varies widely by patient response. Common patterns: 1 infusion every 2 weeks initially, gradually extending to every 4-8 weeks as response is sustained. Some patients achieve remission and discontinue maintenance entirely.
How long do effects of ketamine last? +
Acute antidepressant effects from a single infusion typically last 1-2 weeks. Full induction series produces benefit lasting 2-4 months for many responders. Sustained response often requires ongoing maintenance infusions, similar to how diabetes is managed with ongoing medication rather than cured.
Is ketamine therapy safe? +
IV ketamine at sub-anesthetic therapeutic doses in a clinical setting has a strong safety profile when properly administered. Common short-term effects include dissociation (expected), transient blood pressure elevation, nausea (10-15%), and grogginess. Serious complications are rare. Abuse risk is low in controlled clinical setting. Long-term high-frequency maintenance carries some bladder dysfunction risk.
Does ketamine work for anxiety or PTSD? +
Best evidence is for treatment-resistant depression. PTSD evidence is meaningful but less robust than depression evidence. Anxiety as primary diagnosis has limited evidence - ketamine for "anxiety alone" without depression is not well-supported. Some patients with comorbid depression and anxiety see both improve.
What is the difference between IV ketamine and Spravato? +
Spravato (esketamine) is the FDA-approved nasal spray version, administered in monitored clinic settings under REMS protocol. IV ketamine is the same drug administered intravenously, used off-label. IV ketamine has more years of clinical evidence; Spravato has FDA approval and insurance coverage. Both work via the same NMDA receptor mechanism. Outcomes are broadly comparable.
Is at-home ketamine safe and effective? +
At-home ketamine (oral or sublingual lozenges prescribed via telehealth platforms like Mindbloom, Better U, Joyous) has less monitoring, less consistent absorption, and less established evidence than clinic IV ketamine. DEA scrutiny in 2023-2026 has tightened legal availability. Some patients respond well; some develop dependence. For most patients with treatment-resistant depression, monitored clinic-based ketamine (IV or Spravato) is the more-evidence-supported path.
What is the response rate for ketamine in depression? +
Approximately 60-70% of treatment-resistant depression patients show meaningful response (50%+ reduction in depression scores) to a 6-infusion ketamine induction series. About 30-40% achieve full remission. About 30-40% have inadequate or no response. Response rates are higher than continued antidepressant trials for treatment-resistant patients.
Can I take other medications during ketamine treatment? +
Most antidepressants (SSRIs, SNRIs, atypicals) can be continued during ketamine treatment and are typically maintained. Benzodiazepines may reduce ketamine's antidepressant effect and should be tapered or held on infusion days. Lamotrigine may reduce ketamine response. Always coordinate with your prescribing psychiatrist.
Who should not get ketamine therapy? +
Absolute contraindications: active psychosis or schizophrenia, uncontrolled hypertension, history of severe substance abuse disorder, pregnancy, allergy to ketamine. Strong cautions: bipolar disorder (without mood stabilizer coverage), active suicidal ideation without inpatient capability, history of dissociative disorders.
Why is ketamine so expensive without insurance? +
Clinic ketamine pricing reflects: physician time, nursing/monitoring staff, IV supplies, ketamine itself (relatively inexpensive), clinic overhead, the 60-90 minute time commitment per session, and the cash-pay nature of off-label treatment. Spravato (FDA-approved) is similarly expensive cash but more often insurance-covered, making it the more affordable path for many patients.
Glossary of Terms
Key terminology used throughout this page.
- Treatment-resistant depression (TRD)
- Depression that has not responded to at least 2 adequate trials of antidepressants from different classes. The primary indication for ketamine therapy.
- Dissociation
- The altered state of consciousness experienced during ketamine infusion. Sense of detachment from body, altered time perception, sometimes visual phenomena. Considered an expected effect, not a side effect.
- Spravato
- Esketamine nasal spray, the FDA-approved version of ketamine for treatment-resistant depression and major depression with acute suicidal ideation. Same mechanism as IV ketamine; different administration route.
- PHQ-9
- Patient Health Questionnaire-9. Standard nine-item depression severity scale used to track ketamine response. Score 0-27, with 10+ indicating moderate depression.
- NMDA receptor
- N-methyl-D-aspartate receptor. The glutamate receptor that ketamine modulates, distinct from the monoamine systems targeted by SSRIs and SNRIs. The mechanism explains ketamine's rapid onset.
- Induction series
- The initial protocol of 6 ketamine infusions over 2-3 weeks designed to produce maximum antidepressant response. Standard before transitioning to maintenance protocol.
- KAP (Ketamine-Assisted Psychotherapy)
- Integration of psychotherapy sessions before, during, or after ketamine treatment to maximize therapeutic outcomes. Adds substantial cost but improves long-term durability for some patients.
- REMS
- Risk Evaluation and Mitigation Strategy. The FDA program governing Spravato administration, requiring monitored clinic settings and 2-hour post-administration observation.
Clinical Outcome Data
Published outcome metrics for Ketamine Infusion Therapy drawn from peer-reviewed clinical literature and registry data.
Sources
Clinical evidence cited on this page. ProcedureFinder sources primary clinical research, FDA records, and major professional society guidelines.
- Wilkinson ST et al. "The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation." Am J Psychiatry, 2018. (Acute antidepressant and antisuicidal effects)
- Wilkinson ST et al. "American Society of Ketamine Physicians, Psychotherapists, and Practitioners Clinical Guidelines." 2025. (Standard of care for clinical ketamine practice)
- FDA prescribing information for Spravato (esketamine). (FDA-approved esketamine indication and protocol)
- McIntyre RS et al. "Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression." Am J Psychiatry, 2024. (Comparative effectiveness review)
- American Psychiatric Association Task Force Report on Ketamine, 2023. (Guidelines on clinical use of ketamine)
How We Calculate Miami Pricing
The price ranges shown reflect cash-pay (out-of-pocket) pricing observed across Miami-area providers, adjusted for the local cost index of 1.18x the national average. National benchmark data is blended from provider price surveys, published procedure pricing, and patient-reported costs. Pricing reflects 2026 data and is updated quarterly.
Read our full methodology →Medical Disclaimer
The information on this page is educational. It is not medical advice and does not substitute for evaluation by a licensed provider. Cost ranges are estimates; individual quotes vary. Always consult a qualified clinician before making medical decisions.
More Mental Health Resources
Ready to compare Miami providers?
Get matched with 2 to 4 verified ketamine infusion therapy providers in Miami. Free, no obligation, no spam.